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Abstract 
Introduction: Hepatitis B is the most common form of viral hepatitis. Much has been done for the prevention of Hepatitis B transmission 
from mother to child. However, there is still very limited evidence looking at maternal obstetrics and perinatal outcomes, such as 
gestational diabetes, antepartum haemorrhage and preterm labour, hypertensive disorders in pregnancy and small for gestational age, with 
Hepatitis B infected women. These adverse pregnancy outcomes, if significant, may affect future antenatal care and have a negative impact 
on public health. This study aims to determine the association between these adverse pregnancy and neonatal outcomes with maternal 
Hepatitis B carrier state. 
Methods: This is a retrospective cohort study comparing adverse pregnancy and neonatal outcomes in primigravid women who delivered 
singleton babies after 24 completed weeks of gestation and are carrier for Hepatitis B virus with those who are non-carrier for Hepatitis B 
virus, between 1992 and 2013 in Aberdeen Maternity Hospital. The adverse pregnancy and neonatal outcomes studied include hypertensive 
disorders in pregnancy, antepartum haemorrhage, preterm birth <37 weeks, induction of labour, caesarean delivery, low birth weight and 
admission to neonatal unit. Data was extracted from the Aberdeen Maternity and Neonatal Databank (AMND), which was established in 
1950 to record all pregnancy-related events occurring in Aberdeen city and district in the northeast of Scotland. Statistical analysis was 
done with SPSS version 21 using independent samples t-test for normally distributed continuous variables and chi-squared test for 
categorical variables. Multivariate logistic regression analysis using a multilevel random effects regression model was also conducted to 
adjust for confounding factors.  
Results: The data set contained a sample size of 35116 primigravid women with singleton pregnancies, with 59 being carrier for Hepatitis 
B virus (represented by positive HBsAg status). HBsAg-positive women had significantly lower mean Body Mass Index and were more 
likely to be from the manual social class (registrar general’s occupation-based social class). On unadjusted analysis, there were no 
significant differences in the prevalence of all maternal and perinatal outcomes in both groups. However, after adjusting for confounding 
factors, HBsAg-positive women were more likely to have smaller babies (aOR 4.28; 95% CI 1.57-11.66).  
Conclusion: Our study suggested higher frequencies of low birth weight babies in women with hepatitis B infection. We found no 
statistically significant differences in other adverse pregnancy and perinatal outcomes. As current evidence still shows inconsistent results, 
further research evaluating the possible effects of Hepatitis B viraemia on pregnancy outcomes is justified.  
Introduction 
Hepatitis B is the most common and serious form of viral hepatitis. 
According to the World Health Organization (WHO), it is estimated 
that more than 2 billion people worldwide have been infected with 
Hepatitis B virus. Of these, approximately 360 million people are at 
risk of developing serious problems and death, mainly due to liver 
cirrhosis and hepatocellular carcinoma (HCC)(1).  
Much has been done for the prevention of Hepatitis B transmission 
from mother to child. According to the NICE clinical guideline 62, all 
pregnant women should be offered screening for Hepatitis B infection 
to identify babies who will need vaccination and immunoglobulin to 
prevent mother-to-child transmission of Hepatitis B infection (2). A 
meta-analysis of randomised controlled trials of Hepatitis B vaccine 
administration at birth concluded that vaccination and Hepatitis B 
immunoglobulin significantly prevent Hepatitis B occurrence in 
newborns to Hepatitis B surface antigen (HBsAg) positive mother (3).   
However, there is still limited evidence looking at maternal and 
perinatal outcomes with Hepatitis B infected women. Although 
conflicting, in recent years, some reports have suggested that the 
incidence of gestational diabetes (GDM)(4-6, 15), antepartum 
haemorrhage (APH)(4) and preterm labour (PTL)(7-8, 14) are higher with 
Hepatitis B carrier state whilst the incidence of hypertensive disorders 
of pregnancy (5,9,16) and small for gestational age (SGA)(6, 8) are reduced 
in these women, the pathophysiology of these is not clear.  
 
 
These adverse pregnancy outcomes, if significant can affect future 
antenatal care and have serious impact on public health.  
This study aims to determine the association between these adverse 
pregnancy and neonatal outcomes with maternal Hepatitis B carrier state. 
Materials and Methods 
Data source 
In 1950, The Aberdeen Maternity and Neonatal Databank (AMND) was 
established to record all pregnancy-related events occurring in Aberdeen 
city and district, in the northeast of Scotland. The medical data are coded 
using criteria taken from the ninth and tenth revisions of the International 
Classification of Diseases (ICD-9 and -10). Details of routine hepatitis B 
testing have been included in the AMND database only from 1992. Data 
for this study was extracted from this database using predetermined 
criteria (10).  
Study population 
The study population was limited to primigravid women in order to 
minimise the confounding effect of parity and to avoid double counting of 
infected women. We included all women who delivered singleton babies 
after 24 completed weeks of gestation between 1992 and 2013 in 
Aberdeen Maternity Hospital.  
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Study design 
This is a cohort study where the exposed cohort comprised of women 
with positive HBsAg, and the unexposed cohort comprised of women 
with negative HBsAg, who delivered at the same hospital during the 
same time period. Demographic information including maternal age, 
social class, smoking status, body mass index (BMI) and antenatal and 
perinatal outcomes including hypertensive disorders in pregnancy 
(gestational hypertension, pre-eclampsia, severe pre-eclampsia and 
eclampsia), cholestasis, APH, PTB (coded as delivery before 37 weeks 
of gestation), induction of labour, low birth weight (LBW) (birth 
weight less than 2500g), mode of delivery and admission to neonatal 
unit (NNU). 
Statistical analysis 
Statistical analysis was done using SPSS version 21. The differences 
between normally distributed continuous variables were analysed 
using independent samples t-test and categorical variables compared 
using chi-squared test. Univariate analysis was conducted to identify 
relationships between each antenatal and perinatal outcome and 
HBsAg status without adjusting for confounding factors. Unadjusted 
odds ratio was generated. Here, binary logistic regression was used. 
Multivariate logistic regression analysis was carried out to identify the 
relationship between each maternal or perinatal outcome and HBsAg 
positive status by adjusting for confounding variables. Here, a 
multivariable random effects regression model was used. The 
sociodemographic variables that showed significant association at the 
5% level of significance with HBsAg positive status on univariate 
analysis were included in the model to obtain adjusted odds ratios with 
95% confidence intervals. 
Permission to carry out the study was granted by the steering 
committee of the Aberdeen Maternity and Neonatal Databank. As only 
anonymised routinely collected data were used in the analysis, formal 
ethical approval was not considered necessary by the North of 
Scotland Research Ethics Service. 
Results 
The data set obtained from the AMND contained a total sample size of 35 
116 primigravid women with singleton pregnancies. Statistical analysis 
was performed on all 35 116 women, with 59 being carrier for Hepatitis B 
virus (represented by positive HBsAg status).   
Table 1 represents the sociodemographic characteristics of women in 
relation to their HBsAg status. HBsAg-positive women had significantly 
lower mean body mass index  as compared to HBsAg-negative women 
despite similar mean maternal age and smoking status. Of women with 
HBsAg positive status, 66.1% were from the manual social class (registrar 
general’s occupation-based social class), whereas 51.2% of those with 
HBsAg negative status were from the manual social class. This difference 
was statistically significant. 
Characteristics HBsAg status  
p-value Positive Negative 
Number 59 35057 - 
Mean maternal age in 
years (Std dev) 
27.44 (4.54) 27.41 (5.89) 0.97 
Social class 
Manual (%) 
Non-manual (%) 
 
66.1 
33.9 
 
51.2 
48.8 
 
0.03 
Smoking status 
Non-smoker (%) 
Smoker (%) 
 
69.5 
30.5 
 
70.1 
29.9 
 
0.90 
Mean Body Mass Index 
(std dev) 
23.09 (3.12) 25.01 (4.92) 0.01 
Pre-existing diabetes 
mellitus (%) 
0 (0) 274 (0.8) - 
Pre-existing 
hypertension (%) 
1 (1.7) 1901 (5.4) 0.378 
Table 1: Maternal sociodemographics in relation to maternal HBsAg 
status. 
Characteristics HBsAg Unadjusted OR  
(95% CI) 
 
p-value 
Adjusted OR 
(95% CI)* 
 
p-value Positive Negative 
Number 59 35057 - - - - 
Hypertensive disorders in 
pregnancy (%) 
10.2 20.4 0.44 (0.19-1.03) 0.05 0.35 (0.11-1.12) 0.08 
Cholestasis (%) 0 0 - - - - 
Antepartum haemorrhage (%) 10.2 13.0 0.76 (0.33-1.77) 0.70 0.65 (0.23-1.81) 0.41 
Mean gestation at delivery in 
weeks (std dev) 
Preterm birth <37 weeks (%)** 
39.07 (3.87) 
5.1 
39.22 (2.40) 
8.9 
0.98 
(0.89-1.08) 
0.55(0.17-1.75) 
0.63 
 
0.49 
- 
 
0.50(0.12-2.05) 
- 
 
0.33 
Induction of labour (%)*** 35.6 37.5 0.92(0.54-1.57) 0.785 1.39(0.75-2.56) 0.30 
Mode of delivery  
Vaginal delivery (including 
instrumental) (%) 
Caesarean delivery (%)**** 
 
66.1 
 
33.9 
 
73.5 
 
26.5 
 
1.42 
(0.83-2.44) 
 
0.24 
 
1.92 
(1.00-3.70) 
 
0.05 
Mean birth weight in grams 
(std dev) 
Low birth weight (%)***** 
3143.22 
(833.36) 
11.9 
3307.31 
(624.97) 
8.4 
1.00 (0.99-1.00) 
1.47(0.67-3.25) 
0.44 
 
0.34 
- 
 
4.28(1.57-11.66) 
- 
 
0.005 
Admission to NNU(%)****** 20.0 17.0 1.22 (0.63-2.37) 0.59 1.30(0.55-3.09) 0.55 
Table 2: Association between maternal HBsAg Status and maternal and perinatal outcomes 
*All adjusted OR were adjusted for maternal age, smoking, BMI and 
social class 
**OR for preterm birth was also adjusted for induction of labour 
***OR for induction of labour was also adjusted for hypertension 
disorder in pregnancy and antepartum haemorrhage 
****OR for caesarean delivery was also adjusted for induction of 
labour, hypertension disorder in pregnancy and antepartum 
haemorrhage 
*****OR for LBW was also adjusted for induction of labour, 
hypertension disorder in pregnancy, antepartum haemorrhage and 
preterm birth 
******OR for admission to NNU was also adjusted for preterm birth 
and low birth weight. 
Table 2 showed the association between maternal HBsAg status and 
maternal and perinatal outcomes. There were no cases of cholestasis in 
both groups of women. On unadjusted (univariate) analysis, there were no 
significant differences in the prevalence of hypertensive disorders in 
pregnancy, APH, PTB, IOL, caesarean delivery, LBW and admission to 
NNU in both groups. After adjusting for confounding factors, HBsAg 
positive women were more likely to have smaller babies compared to 
HBsAg negative women (adjusted OR, aOR 4.28; 95% CI 1.57-11.66).  
Discussion  
Our study suggested higher frequencies of LBW babies in women with 
hepatitis B infection. Otherwise, we found no statistically significant 
differences in other adverse pregnancy and perinatal outcomes.  
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The main strength of our study is that it involved a sizeable cohort of 
women with Hepatitis B carrier state for a very low-prevalence area. 
This has contributed to the existing data on maternal and perinatal 
outcomes of women with Hepatitis B carrier state. However, this 
number is still relatively very small resulting in limitations in the 
statistical analysis. Another weak point is that this data set included all 
women with positive HBsAg regardless of their stages of infection, as 
the AMND does not contain details of other viral antigen status or 
liver function tests. This would have significantly skewed the data, as 
treatment for acute hepatitis and fulminant liver failure might involve 
immediate termination of the pregnancy leading to PTB and/or 
caesarean delivery (11-13). However, the likelihood of getting a case of 
that severity in this small number of HBsAg-positive women is low.    
Studies done by Lao et al. (5) and Connell et al. (6) showed no 
association between women with Hepatitis B carrier status and babies 
with LBW. However, our study suggested higher frequencies of LBW 
babies in women with hepatitis B infection. Safir et al. (8) reported 
results in accordance to our study (aOR 1.3; 95% CI 1.1-1.7), but their 
data was analysed by combining women with Hepatitis B and 
Hepatitis C carrier status as a group. Connell et al. argued that 
Hepatitis B and Hepatitis C might not affect pregnancies in a similar 
way (6). 
To date, studies conducted around the world still show very varied results. 
In our centre, we would still recommend closer monitoring of fetal growth 
in Hepatitis B carrier women.  
We found no statistically significant differences in other adverse 
pregnancy and perinatal outcomes, which include hypertensive disorders 
in pregnancy, APH, PTB, IOL, caesarean delivery and admission to NNU. 
A matched controlled study from Hong Kong (4) and a few studies from 
USA (6-7), Germany (18) and Israel (8) where prevalence of Hepatitis B 
infection is low, also showed no association between hypertensive 
disorders of pregnancy and Hepatitis B status. On contrary, a few 
retrospective cohort studies done in Hong Kong, where the prevalence of 
Hepatitis B is high found lower incidence of hypertensive disorders of 
pregnancy in women with Hepatitis B infection (5,9,16). The most likely 
mechanism behind a reduced incidence of hypertensive disorders in 
pregnancy in women with positive HBsAg is an impaired immune 
response in these women which increases their immunotolerance to the 
embryo, thus facilitates placental implantation and contributes to a lower 
incidence of hypertensive disorders (9). The number of HBsAg positive 
women in our study is probably too small to demonstrate significance in 
this matter.  
Authors / Year of 
publication 
Reddick 2010 Tse 2005 Lobstein 2011 Lao 2012 Lao 2007 
Details of study USA 1995-2005 
N=814 
Logistic regression Data 
Hong Kong 2000-2002 
N=253 
Matched control 
Germany 
2001-2006 
N=39 
Hong Kong 1995-2009 
N=8634 
Retrospective cohort study 
Hong Kong1998-2001 
N=1138 
(Not adjusted) 
Low social status N/A N/A  N/A N/A 
Smoking N/A N/A N/A N/A  
Substance misuse  N/A N/A N/A N/A 
Single marital status N/A N/A NS N/A N/A 
BMI N/A NS NS   
Hypertensive disorders NS (PET) NS (PET) NS (PET)   
Gestational diabetes NS  No cases NS  
Cholestasis N/A N/A N/A N/A N/A 
Antepartum 
haemorrhage 
NS  NS  NS 
Preterm birth <37w  NS NS NS N/A 
IOL N/A N/A N/A N/A N/A 
Caesarean delivery  NS NS N/A NS 
Mean BW N/A NS NS  NS 
LBW N/A N/A N/A N/A NS 
SGA/IUGR NS NS N/A N/A NS 
Table 3: Summary of studies on effects of Hepatitis B infection in pregnancy. 
Authors / Year of publication Safir  2010 Wong 1999 To 2003 Connell 2011 
Details of study Israel 1988-2007 
N=749 
Hong Kong June 1996- Sep 1998  
N=824 
Hong Kong 4 years 
N=1340 
Florida 1998-2007 
N=1458 
Low social status N/A Unknown Unknown N/A 
Smoking N/A Unknown Unknown  
Substance misuse N/A Unknown Unknown  
Single marital status N/A Unknown Unknown  
BMI N/A Unknown Unknown N/A 
Hypertensive disorders NS N/A  NS (PET) 
Gestational diabetes NS Unknown Unknown  
Cholestasis N/A Unknown Unknown N/A 
Antepartum haemorrhage N/A Unknown Unknown NS (abruption & PPM) 
Preterm birth <37w  NS Unknown NS 
IOL  Unknown Unknown NS 
Caesarean delivery  Unknown Unknown  
Mean BW N/A Unknown Unknown N/A 
LBW  Unknown Unknown NS 
SGA/IUGR NS NS Unknown  
N/A – Not available , NS – Not significant ,PET – Pre-eclampsia , PPM – Placenta Praevia. 
Table 3: showed an overview of the studies looking at the effects of Hepatitis B infection in pregnancy. These studies around the world have reported 
conflicting results on the association of APH, PTB, IOL, caesarean delivery and admission to NNU with Hepatitis B infection status. Further research 
evaluating the effects of Hepatitis B viraemia on pregnancy outcomes is justified.  
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Conclusion 
Our study suggested higher frequencies of LBW babies in women 
with positive HBsAg status but did not find any significant differences 
in other adverse pregnancy and perinatal outcomes. Although current 
evidence still shows inconsistent results, we would recommend closer 
fetal growth monitoring in HBsAg positive women in our centre. A 
prospective research study to evaluate the effects of Hepatitis B 
viraemia on pregnancy outcomes is justified to provide better 
information to guide the antenatal care of this group of women.  
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